News
MRVI
6.22
+1.63%
0.10
The Disinflation Trade Has A New Address: Genomics
Seeking Alpha · 2d ago
Merck's Bio-Techne buyout put Life Sciences sector in focus: top quant-rated stocks
Seeking Alpha · 3d ago
Weekly Report: what happened at MRVI last week (0615-0619)?
Weekly Report · 6d ago
Maravai Lifesciences announces opening of GMP enzyme manufacturing facility
TipRanks · 06/16 12:35
TriLink, Maravai LifeSciences unit, opens GMP enzyme manufacturing facility in Florida
PUBT · 06/16 12:30
Maravai unit TriLink opens GMP enzyme manufacturing facility in Florida expansion
PUBT · 06/16 12:30
Weekly Report: what happened at MRVI last week (0608-0612)?
Weekly Report · 06/15 09:25
Maravai LifeSciences General Counsel Kurt Oreshack disposes of shares worth $253,000
PUBT · 06/10 21:07
Weekly Report: what happened at MRVI last week (0601-0605)?
Weekly Report · 06/08 09:23
Maravai LifeSciences refinances debt with $180M credit facilities; lowers outstanding borrowings
Seeking Alpha · 06/03 13:45
Maravai LifeSciences Refinances Debt, Extends Credit Facilities
TipRanks · 06/03 13:03
Maravai Lifesciences announces refinancing of credit agreement
TipRanks · 06/03 12:48
MARAVAI LIFESCIENCES ANNOUNCES REFINANCING OF CREDIT AGREEMENT, EXTENDING MATURITY TO 2032
Reuters · 06/03 12:30
MARAVAI LIFESCIENCES - ANNOUNCES NEW CREDIT AGREEMENT WITH $150 MLN TERM LOAN AND $30 MLN REVOLVING FACILITY
Reuters · 06/03 12:30
Weekly Report: what happened at MRVI last week (0525-0529)?
Weekly Report · 06/01 09:25
Maravai Lifesciences Shareholders Back Board, Pay, Auditor
TipRanks · 05/29 21:28
Maravai LifeSciences shareholders ratify Deloitte as independent auditor for 2026
PUBT · 05/29 20:20
Weekly Report: what happened at MRVI last week (0518-0522)?
Weekly Report · 05/25 09:26
Maravai LifeSciences CFO joins Jefferies Global Healthcare Conference fireside chat
PUBT · 05/18 20:00
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
Barchart · 05/18 15:00
More
Webull provides a variety of real-time MRVI stock news. You can receive the latest news about Maravai Lifesciences Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.